@adrsteph.base.eth
The institutional money sitting on the sidelines of DeSci is waiting for one thing: proof that normal people will actually use these protocols. Not crypto natives. Not early adopters. Actual wealthy individuals who care about longevity but will never touch anything that compromises medical privacy.
The addressable market is staring us in the face. $850 billion across five segments.
Medical research $310B. Private health consulting: $220B. Longevity supplements and testing: $180B. Biohacking devices: $95B. Wellness apps and tracking: $45B.
Table d’Adrian sits at the intersection of the highest-addressable segments. Private consulting and wellness tracking. The markets where people already pay premium prices for optimization protocols and want verifiable results.
zkTLS solves the privacy blocker. Table d’Adrian launches Q1 2026 with privacy-preserving health verification on Base. When hospitals and clinics see verified user adoption with real biomarker improvements, the partnerships follow.
When VCs see on-chain demand through buy-and-burn mechanics tied to fiat subscriptions, the capital follows.
The $50 trillion longevity market is not waiting for DeSci to mature.
It is waiting for projects that solve privacy first. We are building that infrastructure now while competitors are still writing whitepapers about problems we already solved.
0 reply
23 recasts
0 reaction